A prospective study to investigate unilateral pain and premonitory symptoms to predict the response to frovatriptan in patients with migraine.
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2015
At a glance
- Drugs Frovatriptan (Primary)
- Indications Migraine without aura
- Focus Therapeutic Use
- 18 Aug 2015 New trial record